BOC Sciences offers comprehensive one-stop antibody-drug conjugate research and evaluation services.
BOC Sciences provides customers with comprehensive one-stop services for all aspects of antibody-drug conjugate research and evaluation, from antibody modification and conjugation, cytotoxin development, cytotoxin-linker synthesis, ADC manufacturing, to ADC characterization and evaluation various stages.
Mar 27, 2024
Combinations of ADCs with various other types of anticancer drugs, such as chemotherapy, radiotherapy, endocrine therapy, targeted molecular agents, and immunotherapy, are being explored in preclinical models and clinical trials.
Apr 10, 2024
The bystander effect means that some ADCs also have anti-tumor activity against other tumor cells surrounding the target target antigen tumor cells, regardless of whether these cells express the target antigen.